Melanoma-associated retinopathy after starting immunotherapy for metastatic cutaneous melanoma

Eye (Lond). 2022 Dec;36(12):2361-2362. doi: 10.1038/s41433-022-02057-8. Epub 2022 Apr 15.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Immunologic Factors
  • Immunotherapy / adverse effects
  • Melanoma* / drug therapy
  • Melanoma* / pathology
  • Melanoma, Cutaneous Malignant
  • Paraneoplastic Syndromes, Ocular*
  • Skin Neoplasms* / pathology

Substances

  • Immunologic Factors